Home > Healthcare > Medical Devices > neonatal infant care market
Get a free sample of Neonatal Infant Care Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Neonatal Infant Care Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Key players in the market are actively enhancing their product offerings through technological innovations and strategic collaborations. For instance, GE Healthcare has introduced advanced neonatal monitoring systems that integrate AI for early complication detection. Drager and Philips Healthcare continue to lead with their high-quality incubators and respiratory support devices. Additionally, these companies are forging partnerships with hospitals and healthcare providers to improve neonatal care practices and expand their market presence. These ongoing developments are vital in driving the evolution of neonatal care, offering more effective solutions for neonatal health challenges.
Prominent players operating in the neonatal infant care industry include:
The U.S. neonatal infant care market was valued at approximately USD 1 billion in 2024 and is expected to grow at a 6% CAGR from 2025 to 2034, supported by an advanced healthcare system and high preterm birth rates.
Key players in the market include Angelantoni Life Science, ATOM MEDICAL, Becton, Dickinson, and Company, COBAMS, DAVID, Drager, Fanem, Fisher & Paykel Healthcare, GE Healthcare, INSPIRATION HEALTHCARE GROUP, Masimo, and Medtronic.
The global neonatal infant care industry was valued at USD 3.4 billion in 2024 and is projected to grow at a 7% CAGR from 2025 to 2034, driven by increasing preterm birth rates and advancements in neonatal technologies.
The thermoregulation devices segment generated USD 859 million in revenue in 2024, holding the largest market share due to their critical role in stabilizing the body temperature of premature and low-birth-weight infants.